01 / PSC Market Profile
PSC AN93 R&D- Medical: Other (Advanced Development) Federal Contracts
Product and Service Code AN93
Federal contract activity classified under R&D- Medical: Other (Advanced Development) across FY 2020–FY 2026. Net obligations include both new obligations and subsequent deobligations.
02 / Market Size
How large is the PSC AN93 federal market?
03 / Spending Trend
PSC AN93 contract spending by fiscal year
Annual obligations, activity, and participation across the same FY 2020–FY 2026 profile window.
Latest closed fiscal year$0
FY 2026| Fiscal year | Obligations | Actions | Vendors | Customers | Change |
|---|---|---|---|---|---|
| FY 2020 | $10.26M | 22 | 15 | 2 | — |
| FY 2021 | $9.07M | 39 | 24 | 3 | −11.7% |
| FY 2022 | $4.15M | 20 | 15 | 3 | −54.3% |
| FY 2023 | -$5.00M | 20 | 10 | 3 | −220.5% |
| FY 2024 | -$68.3K | 16 | 8 | 3 | +98.6% |
| FY 2025 | $3.58M | 6 | 4 | 2 | +5,348.5% |
| FY 2026 | $0 | 4 | 2 | 1 | −100.0% |
04 / Top Federal Customers
Which federal agencies buy most in this industry?
Ranked by net obligations during FY 2020–FY 2026.
| Federal customer | Code | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|
| DEFENSE HEALTH AGENCY (DHA) | 97DH | $11.64M | 21 | 8 | 52.9% |
| DEPT OF THE ARMY | 2100 | $10.19M | 88 | 27 | 46.3% |
| VETERANS AFFAIRS, DEPARTMENT OF | 3600 | $121.5K | 9 | 5 | 0.6% |
| DEPT OF THE AIR FORCE | 5700 | $43.4K | 7 | 1 | 0.2% |
| DEPARTMENTAL OFFICES | 1406 | $0 | 1 | 1 | 0.0% |
| DEFENSE THREAT REDUCTION AGENCY (DTRA) | 9761 | -$2.6K | 1 | 1 | 0.0% |
05 / Contracting Offices
Which contracting offices buy in PSC AN93?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|---|
| ARMY MED RES ACQ ACTIVITY | HT9425 | DEFENSE HEALTH AGENCY (DHA) | $11.64M | 19 | 8 | 52.9% |
| W4PZ USA MED RSCH ACQUIS ACT | W81XWH | DEPT OF THE ARMY | $10.17M | 85 | 26 | 46.2% |
| 246-NETWORK CONTRACTING OFFICE 6 (36C246) | 36C246 | VETERANS AFFAIRS, DEPARTMENT OF | $195.0K | 1 | 1 | 0.9% |
| FA8650 USAF AFMC AFRL PZL AFRL/PZL | FA8650 | DEPT OF THE AIR FORCE | $43.4K | 7 | 1 | 0.2% |
| 262-NETWORK CONTRACT OFFICE 22 (36C262) | 36C262 | VETERANS AFFAIRS, DEPARTMENT OF | $30.3K | 1 | 1 | 0.1% |
| W6QK ACC-APG NATICK | W911QY | DEPT OF THE ARMY | $25.0K | 3 | 1 | 0.1% |
| IBC ACQ SVCS DIRECTORATE (00004) | 140D04 | DEPARTMENTAL OFFICES | $0 | 1 | 1 | 0.0% |
| DEFENSE HEALTH AGENCY | HT9427 | DEFENSE HEALTH AGENCY (DHA) | $0 | 2 | 1 | 0.0% |
| DEFENSE THREAT REDUCTION AGENCY | HDTRA1 | DEFENSE THREAT REDUCTION AGENCY (DTRA) | -$2.6K | 1 | 1 | 0.0% |
| 242-NETWORK CONTRACT OFFICE 02 (36C242) | 36C242 | VETERANS AFFAIRS, DEPARTMENT OF | -$27.4K | 1 | 1 | -0.1% |
06 / Top Vendors
Which contractors lead the PSC AN93 market?
| Vendor | Obligations | Actions | Customers | Market share | Latest activity |
|---|---|---|---|---|---|
| WESTAT, INC. | $13.45M | 17 | 2 | 61.1% | Jul 15, 2026 |
| CERAMEDIX HOLDING, LLC | $4.50M | 6 | 2 | 20.4% | Jul 10, 2023 |
| SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | $4.45M | 7 | 2 | 20.2% | Jan 12, 2026 |
| COOPER CONSULTING SERVICE | $2.65M | 9 | 2 | 12.0% | Jul 16, 2024 |
| SANARIA INC. | $398.3K | 6 | 1 | 1.8% | Jun 3, 2024 |
| ALLIED TECHNOLOGIES & CONSULTING, LLC | $248.6K | 4 | 1 | 1.1% | Sep 18, 2021 |
| EMDX RESEARCH AND CONSULTING ASSOCIATES, LLC | $195.0K | 1 | 1 | 0.9% | Apr 27, 2020 |
| DALTON CHEMICAL LABORATORIES INC | $86.3K | 4 | 1 | 0.4% | Aug 2, 2022 |
| EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $57.5K | 13 | 2 | 0.3% | Jul 17, 2024 |
| KBR WYLE SERVICES, LLC | $43.4K | 7 | 1 | 0.2% | Mar 24, 2025 |
07 / Industry Mix
What industries are purchased under PSC AN93?
| NAICS | Description | Obligations | Actions | Vendors | Share |
|---|---|---|---|---|---|
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $11.61M | 38 | 12 | 52.8% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $8.28M | 38 | 7 | 37.7% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $2.57M | 17 | 4 | 11.7% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | $247.3K | 5 | 2 | 1.1% |
| 541940 | VETERINARY SERVICES | $30.3K | 1 | 1 | 0.1% |
| 611310 | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS | -$27.4K | 1 | 1 | -0.1% |
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | -$719.7K | 27 | 9 | -3.3% |
08 / Buying Pattern
How does the government buy in PSC AN93?
| Common action type | Obligations | Actions |
|---|---|---|
| DEFINITIVE CONTRACT | $21.71M | 112 |
| DELIVERY ORDER | $53.8K | 13 |
| PURCHASE ORDER | $225.3K | 2 |
09 / Recent Contract Awards
What was awarded most recently in PSC AN93?
| Award / PIID | Vendor | Signed date | Obligation | NAICS | Agency / office |
|---|---|---|---|---|---|
| W81XWH15C0048 | WESTAT, INC. | Jul 15, 2026 | $0 | 541711 | DEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCY |
| W81XWH15C0048 | WESTAT, INC. | Apr 1, 2026 | $0 | 541711 | DEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCY |
| W81XWH15C0048 | WESTAT, INC. | Mar 2, 2026 | $0 | 541711 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
| W81XWH20C0116 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | Jan 12, 2026 | $0 | 541715 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
10 / Market Interpretation
How should contractors evaluate this market?
Start with the spending direction
Compare annual obligations with actions and vendor participation. Growth driven by only a few large actions represents a different opportunity from broad, recurring demand.
Follow the actual buyers
Move from federal customers to contracting offices. Offices reveal where acquisition responsibility and recurring purchasing activity are concentrated.
Measure accessible demand
Use competition, small-business participation, incumbent vendors, and PSC mix before treating the full $21.99M market as addressable.